QualityStocks would like to highlight Visualant, Inc. (
OTCQB: VSUL). The company's Spectral Pattern Matching™ (SPM) technology directs structured light onto a substance or material, through a liquid or gas, or off a surface, to capture a unique ChromaID™. A ChromaID can be used to identify, detect, or diagnosis markers invisible to the human eye. ChromaID scanner modules can be integrated into a variety of mobile or fixed-mount form factors. The patented, award-winning technology is disruptive, making it possible to effectively conduct analyses in the field that could only previously be performed by large and expensive lab-based tests.
In the company’s news,
Visualant has received from the U.S. Office of Patents and Trademarks the company’s sixth patent, entitled “Method, Apparatus and Article To Facilitate Distributed Evaluation of Object Using Electromagnetic Energy,” on its ChromaID™ technology.
The new patent is in line with Visualant’s goal to introduce efficient authentication, identification, and diagnostic methods into the marketplace. The news comes quick on the heels of the company’s timely and strategic relationship with Intellectual Ventures, a company that collaborates with leading inventors, partners with pioneering companies, and invests both expertise and capital in the process of invention.
“We rigorously pursue strong protection for our intellectual property. We are very pleased to receive this, our sixth patent,” Ron Erickson, Visualant Founder and CEO, stated in the news release. “…. We have more patents pending and expect more patents to be issued as we build the intellectual property foundation for Visualant’s business and move into the marketplace with diverse applications of our ChromaID technology. This is a process we are accelerating through our new strategic relationship with Intellectual Ventures.”
Devices embedded with the newly patented ChromaID technology can read and record natural chromatic markers by structuring light onto a substance, through a liquid or gas, or off a surface. Once scanned, the technology captures the reflected light and creates a unique ChromaID profile that can be matched against existing databases to identify, detect, or diagnosis markers invisible to the human eye.
About QualityStocks
QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.
To sign up for The QualityStocks Daily Newsletter, please visit
www.QualityStocks.net
To connect with QualityStocks via Facebook, please visit http://Facebook.com/QualityStocksPage
To connect with QualityStocks via Twitter, please visit http://Twitter.com/QualityStocks
Please read FULL disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.net
Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.
